Limiting systemic endocrine overtreatment in postmenopausal breast cancer patients with an ultralow classification of the 70-gene signature

被引:0
|
作者
M. Opdam
V. van der Noort
M. Kleijn
A. Glas
I. Mandjes
S. Kleiterp
F. S. Hilbers
D. T. Kruger
A. D. Bins
P. C. de Jong
P. P. J. B. M. Schiphorst
T. van Dalen
B. Flameling
R. C. Rietbroek
A. Beeker
S. M. van den Heiligenberg
S. D. Bakker
A. N. M. Wymenga
I. M. Oving
R. M. Bijlsma
P. J. van Diest
J. B. Vermorken
H. van Tinteren
S. C. Linn
机构
[1] Netherlands Cancer Institute,Department of Molecular Pathology
[2] Netherlands Cancer Institute,Biometrics Department
[3] Agendia NV,Medical Affairs
[4] Amsterdam UMC,Department of Medical Oncology
[5] Sint-Antonius Hospital,Department of Medical Oncology
[6] Streekziekenhuis Koningin. Beatrix,Department of Internal Medicine
[7] Diakonessenhuis,Department of Surgery
[8] OLVG,Department of Medical Oncology
[9] Red Cross Hospital,Department of Internal Medicine
[10] Spaarne Gasthuis,Department of Medical Oncology
[11] Dijklander Ziekenhuis,Department of Medical Oncology
[12] Zaans Medisch Centrum,Department of Internal Medicine
[13] Medisch Spectrum Twente,Department of Medical Oncology
[14] Ziekenhuisgroep Twente,Department of Medical Oncology
[15] UMCU,Department of Medical Oncology
[16] UMCU,Department of Pathology
[17] University Hospital Antwerp (UZA),Department of Medical Oncology
[18] University of Antwerp,Faculty of Medicine and Health Sciences
[19] Trial and Data Center,Department of Medical Oncology
[20] Princess Maxima Centre for Pediatric Oncology,undefined
[21] Netherlands Cancer Institute,undefined
来源
关键词
Early breast cancer; Postmenopausal; MammaPrint 70-gene signature; Prognosis; Endocrine treatment; Overtreatment;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:265 / 278
页数:13
相关论文
共 50 条
  • [11] Scenarios as a tool for decision making in case of the 70-gene signature for breast cancer patients
    Retel, V. P.
    Rutgers, E.
    van Harten, W. H.
    BREAST, 2009, 18 : S78 - S78
  • [12] Implementation assessment of the 70-gene prognosis signature for breast cancer diagnostics
    Retel, V.
    de Mesquita, J. Bueno
    van't Veer, L.
    van de Vijver, M. J.
    Linn, S. C.
    Hummel, M.
    van Harten, W.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [13] 70-Gene Signature in Early-Stage Breast Cancer REPLY
    van't Veer, Laura J.
    Rutgers, Emiel J. T.
    Piccart, Martine
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (22): : 2200 - 2201
  • [14] Impact of the 70-gene signature on long term breast cancer outcome
    Drukker, C. A.
    van Tinteren, H.
    Schmidt, M. K.
    Rutgers, E. J. T.
    van de Vijver, M. J.
    van't Veer, L. J.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S203 - S203
  • [15] The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer
    Marieke E. Straver
    Annuska M. Glas
    Juliane Hannemann
    Jelle Wesseling
    Marc J. van de Vijver
    Emiel J. Th. Rutgers
    Marie-Jeanne T. F. D. Vrancken Peeters
    Harm van Tinteren
    Laura J. van‘t Veer
    Sjoerd Rodenhuis
    Breast Cancer Research and Treatment, 2010, 119 : 551 - 558
  • [16] The 70-gene signature as a response predictor for neoadjuvant chemotherapy in breast cancer
    Straver, Marieke E.
    Glas, Annuska M.
    Hannemann, Juliane
    Wesseling, Jelle
    van de Vijver, Marc J.
    Rutgers, Emiel J. Th.
    Peeters, Marie-Jeanne T. F. D. Vrancken
    van Tinteren, Harm
    van't Veer, Laura J.
    Rodenhuis, Sjoerd
    BREAST CANCER RESEARCH AND TREATMENT, 2010, 119 (03) : 551 - 558
  • [17] The 70-gene signature test as a prognostic and predictive biomarker in patients with invasive lobular breast cancer
    J. Asher Jenkins
    Schelomo Marmor
    Jane Yuet Ching Hui
    Heather Beckwith
    Anne H. Blaes
    David Potter
    Todd M. Tuttle
    Breast Cancer Research and Treatment, 2022, 191 : 401 - 407
  • [18] The 70-gene signature affects adjuvant systemic treatment decisions in breast cancer patients: A population-based, observational study
    Kuijer, Anne
    van Bommel, Annelotte C. M.
    van der Heiden-van der Loo, Margriet
    Drukker, Carolien A.
    van Dalen, Thijs
    CANCER RESEARCH, 2015, 75
  • [19] The 70-gene signature test as a prognostic and predictive biomarker in patients with invasive lobular breast cancer
    Jenkins, J. Asher
    Marmor, Schelomo
    Hui, Jane Yuet Ching
    Beckwith, Heather
    Blaes, Anne H.
    Potter, David
    Tuttle, Todd M.
    BREAST CANCER RESEARCH AND TREATMENT, 2022, 191 (02) : 401 - 407
  • [20] MammaPrint™ 70-gene signature: another milestone in personalized medical care for breast cancer patients
    Slodkowska, Elzbieta A.
    Ross, Jeffrey S.
    EXPERT REVIEW OF MOLECULAR DIAGNOSTICS, 2009, 9 (05) : 417 - 422